FARMAKOLOGI
KLINIK
Rahmatini
Bagian Farmakologi & Terapi
Fakultas Kedokteran Universitas
Andalas
WHO ( 1988)
Disiplin dalam bidang
kedokteran berdasarkan
prinsip ilmiah, menyatukan
keahlian farmakologi &
keahlian klinik dengan tujuan
meningkatkan manfaat &
keamanan obat
TUJUAN
FARMAKOLOGI KLINIK
Terapi Efektif, Aman , Rasional
RATIONAL DRUG USE
Ratio
Benefit Risk - Cost
F.Kinetika
F Dinamika
F Ekonomi
PHARMACOLOGICAL ASPECTS
IN CLINICAL PRACTICE
Pharmacokinetic
Pharmacodynamic
How drugs act
The dynamics of drug conc. in
the body
* Absorption / bioavailability
* Distribution
* Biotransformation
* Excretion
THERAPEUTIC DRUG
MONITORING (TDM)
Measuring the plasma drug conc.
Provide useful information about
the adequacy of the dosage
regimen or the likehood toxicity
Therapeutic Drug Monitoring (TDM)
Ph dynamic
Ph kinetic
Druginteraction
Measuring/
interpreting
plasma drug conc.
Therapeutic
response
Side effects
Toxic effects
Time-drug conc. relationship
Drug conc. (mg/l)
40
30
Drug toxicity
20
Therapeutic level
10
m.e.c
Low therapy
1
Time (hour)
Therapeutic Drug Monitoring (TDM)
1. Narrow margin of safety drugs
2. Drugs for prevention/ therapy of life threatening
diseases or life saving drugs
3. Difficulty in ditinguishing between the effects
of a disease and the toxic effects of a drug
4. Potent drugs drug amount is very small
5. Drugs that show variability of drug conc.
in plasma
Factors that modify drug plasma
concentration for a given dose
Drug formulation
Drug interaction
Environmental factors
Genetic variation
Renal and hepatic function
Reasons for monitoring
drug treatment
1. To see whether there is
therapeutic response
2. To assess drug toxicity
3. To assess compliance
DRUG
THERAPEUTIC
TOXIC
DIGOXIN
DIPHENYLHI
DANTOIN
LIDOCAIN
PHENOBARBITA
L
THEOPHYLINE
0,0010-0,0022
g/ml
10- 20
1,5-5
15-30
10-20
> 0,0025
> 25
>9
> 40
> 20
Examples of difficulty in ditinguishing between
the effects of a disease and
the toxic effects of a drug
1.
Digoxin toxicity
Congest.Heart Failure
Nausea / anorexia / arrythmias
2.
Gentamycin toxicity
Gram () septicaemia
Renal damage
Drugs- plasma conc.
Pharmacokinetic parameters
Cmax (peak)
Half life
AUC 24
Time
Cmin
(trough)
Visualisation of half-life
Drug conc. (mg/l)
First order elimination of a drug (t : 2 hours)
20
10
The plasma conc. falls by half each half-life
5
2.5
2
Hours
Clinical application of half life (t)
* Designing drug dosage regimen
* Determining time to reach steady state
drug level which show clinical effect
* Determining time to reach the drug level
which have no clinical effect anymore
CONSIDERATION
Phkinetic
Phdynamic
Pheconomic
RATIONAL & GOOD CLINICAL THERAPY
SESUNGGUHNYA BAGIMU,
ADA
MALAIKAT- MALAIKAT YANG
SELALU
MENGAWASI PEKERJAANMU
QS 82 :10